Patent Assignment
Reel/Frame 067245/0714
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded: 2024-04-27
Received: 2024-04-27
Pages: 22
Assignor
PALADIN PHARMA INC.
Executed: 2024-04-24
Assignee
ENDO OPERATIONS LIMITED
FIRST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD, BALLSBRIDGE, IEX, 4, IRELAND
Covered Applications
(22)
METHOD OF TREATING OR REDUCING EFP
App. No. 18/415,270
→
METHODS OF REDUCING COLLAGENASE-MEDIATED BRUISING IN A SUBJECT HAVING CELLULITE
App. No. 18/315,351
→
COLLAGENASE FORMULATIONS AND METHODS OF PRODUCING THE SAME
App. No. 17/419,899
→
COMPOSITIONS AND METHODS FOR TREATING CELLULITE
App. No. 17/276,507
→
INJECTION TECHNIQUES FOR THE TREATMENT OF CELLULITE
App. No. 17/259,784
→
SOLID FORMULATIONS OF LIQUID BIOLOGICALLY ACTIVE AGENTS
App. No. 15/817,907
→
OLIGONUCLEOTIDE DUPLEXES COMPRISING DNA-LIKE AND RNA-LIKE NUCLEOTIDES AND USES THEREOF
App. No. 14/810,148
→
MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
App. No. 14/305,895
→
MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
App. No. 14/305,935
→
MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
App. No. 14/195,813
→
MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
App. No. 14/195,833
→
MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
App. No. 13/919,499
→
MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
App. No. 13/919,476
→
Narcotic Drug Formulations with Decreased Abuse Potential
App. No. 13/133,141
→
OLIGONUCLEOTIDE DUPLEXES COMPRISING DNA-LIKE AND RNA-LIKE NUCLEOTIDES AND USES THEREOF
App. No. 12/996,362
→
MISUSE PREVENTATIVE, CONTROLLED RELEASE FORMULATION
App. No. 12/639,664
→
Misuse Preventative, Controlled Release Formulation
App. No. 12/336,495
→
BILAYER COMPOSITION FOR THE SUSTAINED RELEASE OF ACETAMINOPHEN AND TRAMADOL
App. No. 12/252,117
→
ULTRAPURE 4-METHYLPYRAZOLE
App. No. 11/279,708
→
SUSTAINED-RELEASE TRAMADOL FORMULATIONS WITH 24-HOUR EFFICACY
App. No. 11/112,008
→
Controlled-release compositions
App. No. 11/111,996
→
PROCESS FOR THE PREPARATION OF AMPHIPHILIC POLY (N-VINYL-2-PYRROLIDONE) BLOCK COPOLYMERS
App. No. 10/727,083
→